115 related articles for article (PubMed ID: 488751)
1. Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis.
Douglas JG; Forrest JA; Prowse CV; Cash JD; Finlayson ND
Gut; 1979 Jul; 20(7):565-7. PubMed ID: 488751
[TBL] [Abstract][Full Text] [Related]
2. Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis.
Prowse CV; Douglas JG; Forrest JA; Forsling ML
Eur J Clin Invest; 1980 Feb; 10(1):49-54. PubMed ID: 6768567
[TBL] [Abstract][Full Text] [Related]
3. A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices.
Chiu KW; Sheen IS; Liaw YF
J Gastroenterol Hepatol; 1990; 5(5):549-53. PubMed ID: 1966593
[TBL] [Abstract][Full Text] [Related]
4. The effect of vasopressin and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension.
Rabol A; Juhl E; Schmidt A; Winkler K
Digestion; 1976; 14(3):285-9. PubMed ID: 955334
[TBL] [Abstract][Full Text] [Related]
5. [Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].
Valla D; Lee SS; Moreau R; Hadengue A; Sayegh R; Lebrec D
Gastroenterol Clin Biol; 1985 Dec; 9(12):877-80. PubMed ID: 3830801
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices.
Freeman JG; Cobden I; Lishman AH; Record CO
Lancet; 1982 Jul; 2(8289):66-8. PubMed ID: 6123808
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effect of triglycyl-lysine-vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial.
Cestari R; Braga M; Missale G; Ravelli P; Burroughs AK
J Hepatol; 1990 Mar; 10(2):205-10. PubMed ID: 2185299
[TBL] [Abstract][Full Text] [Related]
8. [Haemodynamic effect of triglycyl-lysine vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial].
Fort E
Gastroenterol Clin Biol; 1990; 14(11):898-9. PubMed ID: 2276578
[No Abstract] [Full Text] [Related]
9. Action of the triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices.
Vosmík J; Jedlicka K; Mulder JL; Cort JH
Gastroenterology; 1977 Apr; 72(4 Pt 1):605-9. PubMed ID: 300062
[TBL] [Abstract][Full Text] [Related]
10. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
[TBL] [Abstract][Full Text] [Related]
11. [Changes in portal hemodynamics during pharmacologic stimulation: somatostatin vs glypressin].
Gerunda GE; Monti G; Maffei Faccioli A
Minerva Med; 1986 Jul; 77(30-31):1433-40. PubMed ID: 2874531
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic effects of triglycyl-lysine vasopressin plus nitroglycerin in patients with HBsAg-positive cirrhosis.
Lin HC; Tsai YT; Chang TT; Lee FY; Wang SS; Lay CS; Lee SD; Lo KJ
J Gastroenterol Hepatol; 1989; 4 Suppl 1():224-7. PubMed ID: 2519061
[No Abstract] [Full Text] [Related]
13. Nitric oxide synthase expression in the splanchnic hyposensitivity to glypressin of a hemorrhage-transfused rat model with portal hypertension.
Huang HC; Chen YC; Wang SS; Chan CC; Lee FY; Chang FY; Lin HC; Hou MC; Lu RH; Wu SL; Lee SD
J Chin Med Assoc; 2004 Jun; 67(6):268-74. PubMed ID: 15366403
[TBL] [Abstract][Full Text] [Related]
14. Ischaemic colitis in a patient treated with glypressin for bleeding oesophageal varices.
Schmitt W; Wagner-Thiessen E; Lux G
Hepatogastroenterology; 1987 Jun; 34(3):134-6. PubMed ID: 3497079
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in haemorrhage-transfused common bile duct-ligated rats.
Lee FY; Chu CJ; Wang SS; Chang FY; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Huang HC; Lee SD
Eur J Clin Invest; 2001 Feb; 31(2):145-53. PubMed ID: 11168453
[TBL] [Abstract][Full Text] [Related]
16. Effect of vasopressin on portal venous pressure.
Kallio H; Lempinen M
Acta Chir Scand; 1983; 149(1):49-52. PubMed ID: 6601347
[TBL] [Abstract][Full Text] [Related]
17. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
Comp PC; Jacocks RM; Rubenstein C; Radcliffe R
J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711
[TBL] [Abstract][Full Text] [Related]
18. Effects of glypressin on human nasal mucosa.
Bende M; Bake B; Flisberg K; Löth S; Ohlin P; Olsson P; Pipkorn U
Acta Otolaryngol; 1986; 102(5-6):488-93. PubMed ID: 3788547
[TBL] [Abstract][Full Text] [Related]
19. Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis.
Merkel C; Bianco S; Bolognesi M; Caregaro L; Amodio P; Sacerdoti D; Gatta A
Am J Gastroenterol; 1992 Nov; 87(11):1580-6. PubMed ID: 1442677
[TBL] [Abstract][Full Text] [Related]
20. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
